Date Title Description PDF
10 May 2023 On P&L The Company releases the first quarter 2023 financial results presentation Download
10 May 2023 On P&L The Company releases the press release related to the first quarter 2023 financial results Download
25 Apr 2023 On business and financial situation ROVI commences clinical development of a new three-monthly formulation of Letrozole (Letrozole LEBE) Download
21 Feb 2023 On business and financial situation The Company releases the press release related to the full year 2022 financial results. Download
21 Feb 2023 On business and financial situation The company releases the Integrated Report for the year 2022 Download

Pages

Date Title Description PDF
31 Jul 2024 Liquidity and counterparty agreements Modification of securities and cash balances associated with the Liquidity Contract signed between the Company and Bestinver, S.V., S.A. Download
08 Jul 2024 Other relevant information The Company informs about the dividends payment.   Download
04 Jul 2024 Liquidity and counterparty agreements Liquidity contract: transactions conducted in the second quarter of 2024 Download
24 Jun 2024 Announcement of General Shareholders' Meeting The Company reports on the resolutions adopted by the Ordinary General Shareholders' Meeting and by the Board of Directors. Download
11 Jun 2024 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 7 June 2024 and 11 June 2024 and end of the share buyback program Download

Pages

Date Title Description PDF
24 Feb 2015 Informe Anual de Gobierno Corporativo 2014 Download
10 Feb 2015 Otros sobre negocio y situación financiera Download
16 Dec 2014 I+D resultados obtenidos; licencias, patentes y marcas Download
06 Nov 2014 información sobre resultados Download
06 Nov 2014 información sobre resultados (2) Download

Pages